Stigmasan
Brand Name: Stigmasan
Generic Name: Neostigmine (as Methylsulfate)
Active
Registration Number
DRP-6823-07
Dosage Form
Solution for Injection (IM/IV/SC)
Issuance Date
December 24, 2024
Expiry Date
September 1, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength500 mcg/mL
PackagingUSP Type I Clear Glass Ampoule X 1 mL / (Box of 6's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Cholinesterase Inhibitors
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Neostigmine (as Methylsulfate)Active
Monograph: neostigmine (as methylsulfate)